Prevention of Heterotopic Bone Formation after Total Hip Arthroplasty in High Risk Patient with Radiation Therapy

1994 ◽  
Vol 29 (7) ◽  
pp. 1738
Author(s):  
Chang Dong Han ◽  
Chong Hyuk Choi ◽  
Chang Ok Suh
1988 ◽  
Vol &NA; (234) ◽  
pp. 102???109 ◽  
Author(s):  
PER KJ??RSGAARD-ANDERSEN ◽  
POUL PEDERSEN ◽  
S??REN SKYDT KRISTENSEN ◽  
STEEN ASMUS SCHMIDT ◽  
NIELS WISBECH PEDERSEN

Orthopedics ◽  
1990 ◽  
Vol 13 (11) ◽  
pp. 1211-1217
Author(s):  
Per Kjærsgaard-Andersen ◽  
Kjeld K Hougaard ◽  
Frank Linde ◽  
Svend Erik Christiansen ◽  
Jørn Jensen

2019 ◽  
Vol 4 (11) ◽  
pp. 640-646 ◽  
Author(s):  
Rory Cuthbert ◽  
James Wong ◽  
Philip Mitchell ◽  
Parag Kumar Jaiswal

Total hip arthroplasty (THA) is one of the most successful surgical procedures – reducing pain and providing functional improvement. However, THA instability is a disabling condition and remains the most common indication for revision THA. To combat the risk of instability, the concept of dual mobility (DM) was developed. This article provides a comprehensive review of DM in the literature. Widespread use of first-generation DM was limited due to concern regarding wear of the polyethylene head and the unique complication of intraprosthetic dislocation (IPD). Implant modifications using highly cross-linked, durable polyethylene and a smooth, cylindrical femoral neck have all but eliminated IPD in contemporary DM. In multiple studies, DM demonstrates statistically significant reductions in dislocation rates comparative to standard bearing primary THA. These results have been particular promising in high-risk patient populations and femoral neck fractures – where low dislocation rates and improved functional outcomes are a recurrent theme. From an economic perspective, DM is equally exciting – with lower accrued costs and higher accrued utility comparative to standard bearing THA. Longer-term clinical evidence and higher-quality prospective comparative studies are required to strengthen current research. Dual mobility may well represent the future gold standard for THA in high-risk patient populations and femoral neck fractures, but due diligence of long-term performance is needed before recommendations for widespread use can be justified. Cite this article: EFORT Open Rev 2019;4:640-646. DOI: 10.1302/2058-5241.4.180089


2014 ◽  
Vol 29 (2) ◽  
pp. 390-392 ◽  
Author(s):  
Carlos J. Lavernia ◽  
Juan S. Contreras ◽  
Jesus M. Villa ◽  
Mark D. Rossi

Sign in / Sign up

Export Citation Format

Share Document